July 28, 2021
Forbes
Related News
-
April 14, 2026First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares’ Automated Cell Shuttle™ Platform
-
February 18, 2026
Cellares and University of Wisconsin School of Medicine and Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors
-
February 03, 2026
Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies
